Sep 03, 2019 8:00am EDT Avalon GloboCare Announces $20 Million Credit Facility Provided by Company Chairman
Jul 15, 2019 8:00am EDT Avalon GloboCare Provides Updates on its Lead Clinical Programs in CAR-T Therapy and Exosome-Based Regenerative Therapeutics
Jun 26, 2019 8:30am EDT Avalon GloboCare Appoints Dr. Yen-Michael Sheng Hsu, Founding Director of cGMP Cellular Therapy Facility at Weill Cornell Medicine, to its Scientific and Clinical Advisory Board
Jun 13, 2019 8:00am EDT Avalon GloboCare President and CEO David Jin, M.D., Ph.D. to Chair the "Research and Application of Stem Cell Exosomes" Session at This Year's Second International Aesthetic Industry Conference
Jun 10, 2019 8:00am EDT Avalon GloboCare Announces Completion of Clinical-Grade Exosome Bio-Production Standardization with Launch of "ACTEX" Product Commercialization
May 21, 2019 9:00am EDT Avalon GloboCare Partners with MIT to Develop Innovative AI-Enhanced Protein Design Technology in Cellular Therapy
Apr 25, 2019 8:58am EDT Avalon GloboCare Announces $6 Million Registered Direct Offering with Institutional Investors
Apr 24, 2019 8:00am EDT Eminent M.I.T. Institute Professor, Robert S. Langer, Sc.D., Joins Avalon GloboCare's Scientific and Clinical Advisory Board
Apr 17, 2019 8:00am EDT Avalon GloboCare to Host The 3rd Annual International Scientific Forum on Exosome Research and Application (ISFERA) in Beijing on July 19, 2019